PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.440.14 (-2.51%)
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.35%
Positive revenue growth while HUH1V.HE is negative. John Neff might see a notable competitive edge here.
12.82%
Gross profit growth above 1.5x HUH1V.HE's 5.29%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
27.13%
EBIT growth 50-75% of HUH1V.HE's 49.48%. Martin Whitman would suspect suboptimal resource allocation.
27.13%
Operating income growth at 50-75% of HUH1V.HE's 49.48%. Martin Whitman would doubt the firm’s ability to compete efficiently.
27.59%
Net income growth at 50-75% of HUH1V.HE's 51.61%. Martin Whitman would question fundamental disadvantages in expenses or demand.
121.43%
EPS growth above 1.5x HUH1V.HE's 50.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
121.43%
Diluted EPS growth above 1.5x HUH1V.HE's 50.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.96%
Share change of 0.96% while HUH1V.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.96%
Diluted share change of 0.96% while HUH1V.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-79.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-142.71%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-29.04%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 70.52%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.85%
5Y revenue/share CAGR under 50% of HUH1V.HE's 18.56%. Michael Burry would suspect a significant competitive gap or product weakness.
1.36%
3Y revenue/share CAGR under 50% of HUH1V.HE's 10.33%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-52.74%
Negative 10Y OCF/share CAGR while HUH1V.HE stands at 322.62%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
172.35%
Positive OCF/share growth while HUH1V.HE is negative. John Neff might see a comparative advantage in operational cash viability.
-43.77%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 171.70%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
121.16%
Net income/share CAGR at 75-90% of HUH1V.HE's 135.33%. Bill Ackman would press for strategic moves to boost long-term earnings.
152.75%
5Y net income/share CAGR above 1.5x HUH1V.HE's 12.57%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
17.95%
3Y net income/share CAGR 1.25-1.5x HUH1V.HE's 13.00%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
40.04%
10Y equity/share CAGR at 50-75% of HUH1V.HE's 69.39%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
41.47%
5Y equity/share CAGR 1.25-1.5x HUH1V.HE's 34.27%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
28.79%
3Y equity/share CAGR above 1.5x HUH1V.HE's 16.83%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.14%
AR growth well above HUH1V.HE's 11.87%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.18%
Inventory growth well above HUH1V.HE's 13.88%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.64%
Asset growth above 1.5x HUH1V.HE's 4.18%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.97%
BV/share growth above 1.5x HUH1V.HE's 6.71%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
2.86%
We have some new debt while HUH1V.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 12.28%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-49.54%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.